Literature DB >> 9288769

Differential messenger RNA and protein expression of the receptor for advanced glycosylated end products in normal lung and non-small cell lung carcinoma.

P Schraml1, I Bendik, C U Ludwig.   

Abstract

The receptor for advanced glycosylated end products (RAGE), a member of the immunoglobulin superfamily, was one of the cDNA subtraction clones that was found to be differentially expressed in human lung and the corresponding tumor tissue. In nine additional matched normal/tumor pairs, a strongly reduced or missing expression, not only on a transcriptional level but also on a protein level, was demonstrated in the non-small cell lung carcinoma tissue. Because amphoterin, a physiological ligand of RAGE that is highly expressed in the lung, mediates cell differentiation via RAGE, a down-regulation of the receptor may be considered as a critical step in lung tumor formation. Furthermore, we determined the complete reading frame of RAGE.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9288769

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

Review 1.  All the "RAGE" in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses.

Authors:  Elizabeth A Oczypok; Timothy N Perkins; Tim D Oury
Journal:  Paediatr Respir Rev       Date:  2017-03-18       Impact factor: 2.726

2.  Association of RAGE polymorphisms and cancer risk: a meta-analysis of 27 studies.

Authors:  Wenjie Xia; Youtao Xu; Qixing Mao; Gaochao Dong; Run Shi; Jie Wang; YanYan Zheng; Lin Xu; Feng Jiang
Journal:  Med Oncol       Date:  2015-01-21       Impact factor: 3.064

Review 3.  The function and mechanism of HMGB1 in lung cancer and its potential therapeutic implications.

Authors:  Lei Wu; Lili Yang
Journal:  Oncol Lett       Date:  2018-03-08       Impact factor: 2.967

Review 4.  The receptor for advanced glycation end products (RAGE) and the lung.

Authors:  Stephen T Buckley; Carsten Ehrhardt
Journal:  J Biomed Biotechnol       Date:  2010-01-19

Review 5.  The multiple faces of RAGE--opportunities for therapeutic intervention in aging and chronic disease.

Authors:  Ravichandran Ramasamy; Alexander Shekhtman; Ann Marie Schmidt
Journal:  Expert Opin Ther Targets       Date:  2015-11-11       Impact factor: 6.902

6.  Protein signature of lung cancer tissues.

Authors:  Michael R Mehan; Deborah Ayers; Derek Thirstrup; Wei Xiong; Rachel M Ostroff; Edward N Brody; Jeffrey J Walker; Larry Gold; Thale C Jarvis; Nebojsa Janjic; Geoffrey S Baird; Sheri K Wilcox
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

7.  Noise filtering and nonparametric analysis of microarray data underscores discriminating markers of oral, prostate, lung, ovarian and breast cancer.

Authors:  Virginie M Aris; Michael J Cody; Jeff Cheng; James J Dermody; Patricia Soteropoulos; Michael Recce; Peter P Tolias
Journal:  BMC Bioinformatics       Date:  2004-11-29       Impact factor: 3.169

8.  The receptor for advanced glycation end products (RAGE) contributes to the progression of emphysema in mice.

Authors:  Nisha Sambamurthy; Adriana S Leme; Tim D Oury; Steven D Shapiro
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

9.  Effect of RAGE gene polymorphisms and circulating sRAGE levels on susceptibility to gastric cancer: a case-control study.

Authors:  Taijie Li; Weijuan Qin; Yanqiong Liu; Shan Li; Xue Qin; Zhiming Liu
Journal:  Cancer Cell Int       Date:  2017-02-06       Impact factor: 5.722

10.  The receptor RAGE: Bridging inflammation and cancer.

Authors:  Astrid Riehl; Julia Németh; Peter Angel; Jochen Hess
Journal:  Cell Commun Signal       Date:  2009-05-08       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.